Literature DB >> 26975361

Characteristics of the Human Upper Gastrointestinal Contents in the Fasted State Under Hypo- and A-chlorhydric Gastric Conditions Under Conditions of Typical Drug - Drug Interaction Studies.

Chara Litou1, Maria Vertzoni1, Constantinos Goumas2, Vassilis Vasdekis3, Wei Xu4, Filippos Kesisoglou4, Christos Reppas5.   

Abstract

OBJECTIVE: Evaluate the impact of reduced gastric acid secretion after administration of two acid-reducing agents on the physicochemical characteristics of contents of upper gastrointestinal lumen of fasted adults.
MATERIALS AND METHODS: Eight healthy male adults, fasted from food for 12 h, participated in a three-phase crossover study. Phase 1: No drug treatment prior to aspirations. Phase 2: Oral administration of 40 mg pantoprazole at ~9 am the last 3 days prior to aspirations and at ~7 am on aspiration day. Phase 3: Oral administration of 20 mg famotidine at ~7 pm prior to aspirations and at ~7 am on aspiration day. Samples from the contents of upper gastrointestinal lumen were aspirated for 50 min, after administration of 240 ml table water at ~9 am.
RESULTS: Reduction of gastric acid secretion was accompanied by reduced buffer capacity, chloride ion concentration, osmolality and surface tension in stomach and by increased pH (up to ~0.7 units) in upper small intestine during the first 50 min post-water administration. The mechanism of reduction of acid secretion seems to be important for the buffer capacity in stomach and for the surface tension in upper gastrointestinal lumen.
CONCLUSIONS: Apart from gastric pH, reduced acid secretion affects physicochemical characteristics of contents of upper gastrointestinal lumen which may be important for the performance of certain drugs/products in the fasted state.

Entities:  

Keywords:  achlorhydria; duodenal composition; fasted state; gastric composition; hypochlorhydria; upper gastrointestinal lumen

Mesh:

Substances:

Year:  2016        PMID: 26975361     DOI: 10.1007/s11095-016-1882-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  37 in total

Review 1.  Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors.

Authors:  C A Stedman; M L Barclay
Journal:  Aliment Pharmacol Ther       Date:  2000-08       Impact factor: 8.171

2.  Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies.

Authors:  Lida Kalantzi; Konstantinos Goumas; Vasilios Kalioras; Bertil Abrahamsson; Jennifer B Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2006-12-01       Impact factor: 4.200

3.  Viscosity-mediated negative food effect on oral absorption of poorly-permeable drugs with an absorption window in the proximal intestine: In vitro experimental simulation and computational verification.

Authors:  Sandra Cvijić; Jelena Parojčić; Peter Langguth
Journal:  Eur J Pharm Sci       Date:  2014-04-18       Impact factor: 4.384

4.  Gastric mucus secretion in ranitidine-treated patients.

Authors:  M Guslandi; E Ballarin; A Tittobello
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-12

5.  Effect of pH and comedication on gastrointestinal absorption of posaconazole: monitoring of intraluminal and plasma drug concentrations.

Authors:  Jeroen Walravens; Joachim Brouwers; Isabel Spriet; Jan Tack; Pieter Annaert; Patrick Augustijns
Journal:  Clin Pharmacokinet       Date:  2011-11-01       Impact factor: 6.447

6.  Determination of intralumenal individual bile acids by HPLC with charged aerosol detection.

Authors:  Maria Vertzoni; Helen Archontaki; Christos Reppas
Journal:  J Lipid Res       Date:  2008-08-07       Impact factor: 5.922

7.  Postprandial evolution in composition and characteristics of human duodenal fluids in different nutritional states.

Authors:  S Clarysse; J Tack; F Lammert; G Duchateau; C Reppas; P Augustijns
Journal:  J Pharm Sci       Date:  2009-03       Impact factor: 3.534

Review 8.  Clinical pharmacology of famotidine: a summary.

Authors:  A N Chremos
Journal:  J Clin Gastroenterol       Date:  1987       Impact factor: 3.062

9.  Upper gastrointestinal pH in seventy-nine healthy, elderly, North American men and women.

Authors:  T L Russell; R R Berardi; J L Barnett; L C Dermentzoglou; K M Jarvenpaa; S P Schmaltz; J B Dressman
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

10.  Characterization of fasted human gastric fluid for relevant rheological parameters and gastric lipase activities.

Authors:  Pernille Barbre Pedersen; Peter Vilmann; Daniel Bar-Shalom; Anette Müllertz; Stefania Baldursdottir
Journal:  Eur J Pharm Biopharm       Date:  2013-05-31       Impact factor: 5.571

View more
  12 in total

1.  Measuring pH and Buffer Capacity in Fluids Aspirated from the Fasted Upper Gastrointestinal Tract of Healthy Adults.

Authors:  Chara Litou; Dimitrios Psachoulias; Maria Vertzoni; Jennifer Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2020-01-27       Impact factor: 4.200

2.  Utilization of In Vitro, In Vivo and In Silico Tools to Evaluate the pH-Dependent Absorption of a BCS Class II Compound and Identify a pH-Effect Mitigating Strategy.

Authors:  Christoph Gesenberg; Neil R Mathias; Yan Xu; John Crison; Ishani Savant; Amy Saari; David J Good; Jeffrey N Hemenway; Ajit S Narang; Richard R Schartman; Naiyu Zheng; Adela Buzescu; Jatin Patel
Journal:  Pharm Res       Date:  2019-10-21       Impact factor: 4.200

3.  Understanding In Vivo Dissolution of Immediate Release (IR) Solid Oral Drug Products Containing Weak Acid BCS Class 2 (BCS Class 2a) Drugs.

Authors:  Min Li; Xinwen Zhang; Di Wu; Om Anand; Hansong Chen; Kimberly Raines; Lawrence Yu
Journal:  AAPS J       Date:  2021-10-26       Impact factor: 4.009

4.  Levothyroxine treatment and gastric juice pH in humans: the proof of concept.

Authors:  Camilla Virili; Giovanni Bruno; Maria Giulia Santaguida; Lucilla Gargano; Ilaria Stramazzo; Corrado De Vito; Alessia Cicenia; Giulia Scalese; Barbara Porowska; Carola Severi; Marco Centanni
Journal:  Endocrine       Date:  2022-04-27       Impact factor: 3.925

5.  In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets.

Authors:  Deanna M Mudie; Aaron M Stewart; Jesus A Rosales; Molly S Adam; Michael M Morgen; David T Vodak
Journal:  Pharmaceutics       Date:  2021-08-13       Impact factor: 6.321

6.  In Vivo Dissolution and Systemic Absorption of Immediate Release Ibuprofen in Human Gastrointestinal Tract under Fed and Fasted Conditions.

Authors:  Mark J Koenigsknecht; Jason R Baker; Bo Wen; Ann Frances; Huixia Zhang; Alex Yu; Ting Zhao; Yasuhiro Tsume; Manjunath P Pai; Barry E Bleske; Xinyuan Zhang; Robert Lionberger; Allen Lee; Gordon L Amidon; William L Hasler; Duxin Sun
Journal:  Mol Pharm       Date:  2017-10-05       Impact factor: 4.939

7.  Selection of In Vivo Predictive Dissolution Media Using Drug Substance and Physiological Properties.

Authors:  Deanna M Mudie; Nasim Samiei; Derrick J Marshall; Gregory E Amidon; Christel A S Bergström
Journal:  AAPS J       Date:  2020-01-27       Impact factor: 4.009

8.  Amorphous Solid Dispersion Tablets Overcome Acalabrutinib pH Effect in Dogs.

Authors:  Deanna M Mudie; Aaron M Stewart; Jesus A Rosales; Nishant Biswas; Molly S Adam; Adam Smith; Christopher D Craig; Michael M Morgen; David T Vodak
Journal:  Pharmaceutics       Date:  2021-04-15       Impact factor: 6.321

9.  A novel architecture for achieving high drug loading in amorphous spray dried dispersion tablets.

Authors:  Deanna M Mudie; Stephanie Buchanan; Aaron M Stewart; Adam Smith; Kimberly B Shepard; Nishant Biswas; Derrick Marshall; Alyssa Ekdahl; Amanda Pluntze; Christopher D Craig; Michael M Morgen; John M Baumann; David T Vodak
Journal:  Int J Pharm X       Date:  2020-02-19

10.  Development of Immediate Release Tablets Containing Calcium Lactate Synthetized from Black Sea Mussel Shells.

Authors:  Magdalena Mititelu; Elena Moroșan; Anca Cecilia Nicoară; Ana Andreea Secăreanu; Adina Magdalena Musuc; Irina Atkinson; Jeanina Pandele Cusu; George Mihai Nițulescu; Emma Adriana Ozon; Iulian Sarbu; Teodora Dalila Balaci
Journal:  Mar Drugs       Date:  2022-01-02       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.